Andrea Poli

Summary

Country: Italy

Publications

  1. doi request reprint Moderate alcohol use and health: a consensus document
    A Poli
    NFI Nutrition Foundation of Italy, Viale Tunisia 38, 20124 Milan, Italy
    Nutr Metab Cardiovasc Dis 23:487-504. 2013
  2. doi request reprint How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort
    A Poli
    Epidemiology and Preventive Pharmacology Centre, SEFAP, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy
    Nutr Metab Cardiovasc Dis 22:327-36. 2012
  3. doi request reprint Reaching LDL-c targets in high-risk patients requires high-efficacy cholesterol-lowering drugs in more than 50% of cases. The results of the CHECK study
    Andrea Poli
    SEFAP, University of Milan, Milan, Italy
    Pharmacol Res 64:393-6. 2011
  4. doi request reprint Reversible and non-reversible cardiovascular risk in patients treated with lipid-lowering therapy: analysis of SEAS and JUPITER trials
    A Poli
    Department of Pharmacological Sciences, University of Milan, Italy
    Eur J Intern Med 21:372-3. 2010
  5. ncbi request reprint Atorvastatin: pharmacological characteristics and lipid-lowering effects
    Andrea Poli
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Drugs 67:3-15. 2007
  6. doi request reprint Probiotics and health: an evidence-based review
    Paolo Aureli
    Microorganisms and Food Technologies Division, Istituto Superiore di Sanita, Rome, Italy
    Pharmacol Res 63:366-76. 2011
  7. doi request reprint C-reactive protein distribution and correlation with traditional cardiovascular risk factors in the Italian population
    Manuela Casula
    Epidemiology and Preventive Pharmacology Centre SEFAP, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milano, Italy
    Eur J Intern Med 24:161-6. 2013
  8. pmc Metabolic syndrome, inflammation and atherosclerosis
    Rodolfo Paoletti
    Department of Pharmacological Sciences, University of Milan, Italy
    Vasc Health Risk Manag 2:145-52. 2006
  9. doi request reprint Clinical pharmacology of n-3 polyunsaturated fatty acids: non-lipidic metabolic and hemodynamic effects in human patients
    Franca Marangoni
    Nutrition Foundation of Italy and University of Milan, Milan, Italy
    Atheroscler Suppl 14:230-6. 2013
  10. doi request reprint Phytosterols and cardiovascular health
    Franca Marangoni
    Nutrition Foundation of Italy, Viale Tunisia 38, 20124 Milano, Italy
    Pharmacol Res 61:193-9. 2010

Detail Information

Publications22

  1. doi request reprint Moderate alcohol use and health: a consensus document
    A Poli
    NFI Nutrition Foundation of Italy, Viale Tunisia 38, 20124 Milan, Italy
    Nutr Metab Cardiovasc Dis 23:487-504. 2013
    ..The aim of this consensus paper is to review the available evidence on the association between moderate alcohol use, health and disease and to provide a working document to the scientific and health professional communities...
  2. doi request reprint How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort
    A Poli
    Epidemiology and Preventive Pharmacology Centre, SEFAP, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy
    Nutr Metab Cardiovasc Dis 22:327-36. 2012
    ..To assess cardiovascular risk distribution, distribution of individual low-density lipoprotein (LDL)-cholesterol target and distance of LDL cholesterol from the target in a representative sample of the Italian population...
  3. doi request reprint Reaching LDL-c targets in high-risk patients requires high-efficacy cholesterol-lowering drugs in more than 50% of cases. The results of the CHECK study
    Andrea Poli
    SEFAP, University of Milan, Milan, Italy
    Pharmacol Res 64:393-6. 2011
    ..Our data might conceivably be applied to other low-cardiovascular risk countries and should be taken into account when defining the proportion of drugs with different efficacy and cost in the everyday clinical practice...
  4. doi request reprint Reversible and non-reversible cardiovascular risk in patients treated with lipid-lowering therapy: analysis of SEAS and JUPITER trials
    A Poli
    Department of Pharmacological Sciences, University of Milan, Italy
    Eur J Intern Med 21:372-3. 2010
    ....
  5. ncbi request reprint Atorvastatin: pharmacological characteristics and lipid-lowering effects
    Andrea Poli
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Drugs 67:3-15. 2007
    ..6 mmol/L (100 mg/dL) to be the goal of antihyperlipidaemic drug therapy in high-risk patients with CHD, with an optional therapeutic target of <1.8 mmol/L (70 mg/dL) in patients at very high risk...
  6. doi request reprint Probiotics and health: an evidence-based review
    Paolo Aureli
    Microorganisms and Food Technologies Division, Istituto Superiore di Sanita, Rome, Italy
    Pharmacol Res 63:366-76. 2011
    ..e. probiotics, is being tested in several settings. This review summarizes the current knowledge on probiotics and discusses both limitations and acquired evidence to support their use in preventive and therapeutic medicine...
  7. doi request reprint C-reactive protein distribution and correlation with traditional cardiovascular risk factors in the Italian population
    Manuela Casula
    Epidemiology and Preventive Pharmacology Centre SEFAP, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milano, Italy
    Eur J Intern Med 24:161-6. 2013
    ..We report the distribution of plasma levels of CRP and its possible relationship with other cardiovascular risk factors in an Italian cohort...
  8. pmc Metabolic syndrome, inflammation and atherosclerosis
    Rodolfo Paoletti
    Department of Pharmacological Sciences, University of Milan, Italy
    Vasc Health Risk Manag 2:145-52. 2006
    ..While no single treatment for the metabolic syndrome as a whole yet exists, emerging therapies offer potential as future therapeutic approaches...
  9. doi request reprint Clinical pharmacology of n-3 polyunsaturated fatty acids: non-lipidic metabolic and hemodynamic effects in human patients
    Franca Marangoni
    Nutrition Foundation of Italy and University of Milan, Milan, Italy
    Atheroscler Suppl 14:230-6. 2013
    ..In this short paper we will review the evidence in support of these pleiotropic effects of n-3 fatty acids. ..
  10. doi request reprint Phytosterols and cardiovascular health
    Franca Marangoni
    Nutrition Foundation of Italy, Viale Tunisia 38, 20124 Milano, Italy
    Pharmacol Res 61:193-9. 2010
    ..Phytosterols, up to 3g/day, are safe and effective cholesterol-lowering agents...
  11. ncbi request reprint The emerging link between nutrition, inflammation and atherosclerosis
    Rodolfo Paoletti
    Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133, Milan, Italy
    Expert Rev Cardiovasc Ther 4:385-93. 2006
    ..Available evidence indicates that dietary intervention should be an integral part of therapeutic approaches for treating conditions such as the metabolic syndrome and, ultimately, for the prevention of cardiovascular disease...
  12. ncbi request reprint Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women
    Andrea Poli
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Obstet Gynecol 102:922-6. 2003
    ..To improve knowledge of the risk factors associated with these conditions, we assessed the relationship between bone mass density and plasma lipid profile in a cohort of postmenopausal women...
  13. doi request reprint The glycemic index of bread and biscuits is markedly reduced by the addition of a proprietary fiber mixture to the ingredients
    Franca Marangoni
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Nutr Metab Cardiovasc Dis 18:602-5. 2008
    ....
  14. doi request reprint Omega-6 and omega-3 polyunsaturated fatty acid levels are reduced in whole blood of Italian patients with a recent myocardial infarction: the AGE-IM study
    Franca Marangoni
    NFI Nutrition Foundation of Italy, Viale Tunisia 38, 20124 Milano, Italy Electronic address
    Atherosclerosis 232:334-8. 2014
    ..The AGE-IM (Acidi Grassi Essenziali e Infarto Miocardico) study was planned to examine the relationships between MI, whole blood fatty acids and the diet in an Italian cohort...
  15. ncbi request reprint Levels of the n-3 fatty acid eicosapentaenoic acid in addition to those of alpha linolenic acid are significantly raised in blood lipids by the intake of four walnuts a day in humans
    Franca Marangoni
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Nutr Metab Cardiovasc Dis 17:457-61. 2007
    ..The aim of this study was to selectively evaluate the effects of moderate walnut consumption on the levels of ALA and its metabolic derivatives in human blood...
  16. ncbi request reprint Cardiovascular risk in diabetic women
    Chara Bolego
    Department of Pharmacological Sciences, University of Milan, Via Balzaretti, 9, 20133 Milan, Italy
    Curr Atheroscler Rep 5:79-81. 2003
  17. doi request reprint n-3 fatty acids: functional differences between food intake, oral supplementation and drug treatments
    Franca Marangoni
    Nutrition Foundation of Italy NFI, Milan, Italy
    Int J Cardiol 170:S12-5. 2013
    ..Critical knowledge of these characteristics allows the selection of the best approach in order to optimise the n-3 PUFA supply in various individuals. ..
  18. ncbi request reprint Pleiotropic effects of statins and early benefit in the PROVE IT-TIMI-22 study
    Andrea Poli
    J Am Coll Cardiol 48:852; author reply 852-3. 2006
  19. doi request reprint Non-pharmacological control of plasma cholesterol levels
    Andrea Poli
    Nutrition Foundation of Italy, Italy
    Nutr Metab Cardiovasc Dis 18:S1-16. 2008
    ..This Consensus document summarizes the view of the panel on this topic, with the aim to provide an updated support to clinicians and other health professionals involved in cardiovascular prevention...
  20. ncbi request reprint Cerebrovascular disease in Italy and Europe: it is necessary to prevent a 'pandemia'
    Antonio Gaddi
    Atherosclerosis and Dysmetabolic Disease Study Centre G Descovich, University of Bologna, Bologna, Italy
    Gerontology 49:69-79. 2003
    ..The aim of this review is to resume the actual knowledge about the epidemiology of cerebrovascular disease in Italy and Europe, and about the means available to prevent this phenomenon...
  21. ncbi request reprint Novel statins: pharmacological and clinical results
    Chiara Bolego
    Nutrition Foundation of Italy, Via S Pietro all Orto 17, 20121 Milan, Italy
    Cardiovasc Drugs Ther 16:251-7. 2002
    ....
  22. ncbi request reprint Cerebrovascular disease in Italy and Europe: it is necessary to prevent a 'pandemia'
    Antonio Gaddi
    Atherosclerosis and Dysmetabolic Disease Study Centre G Descovich, University of Bologna, Italy
    J Cardiovasc Risk 9:143-5. 2002
    ..It is plausible that the application of a suitable early prevention of the cerebrovascular pathology could bring to a more late slatentisation and less serious demonstrations of Alzheimer's disease, when this is destined to develop...